These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23624993)

  • 61. Effects of glucagon-like peptide-1 receptor agonists on renal function.
    Filippatos TD; Elisaf MS
    World J Diabetes; 2013 Oct; 4(5):190-201. PubMed ID: 24147203
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.
    Idorn T; Knop FK; Jørgensen M; Jensen T; Resuli M; Hansen PM; Christensen KB; Holst JJ; Hornum M; Feldt-Rasmussen B
    BMJ Open; 2013; 3(4):. PubMed ID: 23624993
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
    Dejgaard TF; Knop FK; Tarnow L; Frandsen CS; Hansen TS; Almdal T; Holst JJ; Madsbad S; Andersen HU
    BMJ Open; 2015 Apr; 5(4):e007791. PubMed ID: 25838513
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial.
    Gudbergsen H; Henriksen M; Wæhrens EE; Overgaard A; Bliddal H; Christensen R; Boesen MP; Knop FKK; Astrup A; Rasmussen MU; Bartholdy C; Daugaard C; Bartels EM; Ellegaard K; Heitmann BL; Kristensen LE
    BMJ Open; 2019 May; 9(5):e024065. PubMed ID: 31061017
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.
    Ishøy PL; Knop FK; Broberg BV; Baandrup L; Fagerlund B; Jørgensen NR; Andersen UB; Rostrup E; Glenthøj BY; Ebdrup BH
    BMJ Open; 2014 Jan; 4(1):e004158. PubMed ID: 24401727
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial.
    Idorn T; Knop FK; Jørgensen MB; Jensen T; Resuli M; Hansen PM; Christensen KB; Holst JJ; Hornum M; Feldt-Rasmussen B
    Diabetes Care; 2016 Feb; 39(2):206-13. PubMed ID: 26283739
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial.
    Arjona Ferreira JC; Corry D; Mogensen CE; Sloan L; Xu L; Golm GT; Gonzalez EJ; Davies MJ; Kaufman KD; Goldstein BJ
    Am J Kidney Dis; 2013 Apr; 61(4):579-87. PubMed ID: 23352379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.
    National Kidney Foundation
    Am J Kidney Dis; 2012 Nov; 60(5):850-86. PubMed ID: 23067652
    [TBL] [Abstract][Full Text] [Related]  

  • 69. One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment.
    Kothny W; Shao Q; Groop PH; Lukashevich V
    Diabetes Obes Metab; 2012 Nov; 14(11):1032-9. PubMed ID: 22690943
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study.
    Yoo DE; Park JT; Oh HJ; Kim SJ; Lee MJ; Shin DH; Han SH; Yoo TH; Choi KH; Kang SW
    PLoS One; 2012; 7(1):e30072. PubMed ID: 22291903
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Liraglutide: clinical pharmacology and considerations for therapy.
    Sisson EM
    Pharmacotherapy; 2011 Sep; 31(9):896-911. PubMed ID: 21923591
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mild renal impairment and the efficacy and safety of liraglutide.
    Davidson JA; Brett J; Falahati A; Scott D
    Endocr Pract; 2011; 17(3):345-55. PubMed ID: 21700561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*).
    Graefe-Mody U; Friedrich C; Port A; Ring A; Retlich S; Heise T; Halabi A; Woerle HJ
    Diabetes Obes Metab; 2011 Oct; 13(10):939-46. PubMed ID: 21672124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
    Baigent C; Landray MJ; Reith C; Emberson J; Wheeler DC; Tomson C; Wanner C; Krane V; Cass A; Craig J; Neal B; Jiang L; Hooi LS; Levin A; Agodoa L; Gaziano M; Kasiske B; Walker R; Massy ZA; Feldt-Rasmussen B; Krairittichai U; Ophascharoensuk V; Fellström B; Holdaas H; Tesar V; Wiecek A; Grobbee D; de Zeeuw D; Grönhagen-Riska C; Dasgupta T; Lewis D; Herrington W; Mafham M; Majoni W; Wallendszus K; Grimm R; Pedersen T; Tobert J; Armitage J; Baxter A; Bray C; Chen Y; Chen Z; Hill M; Knott C; Parish S; Simpson D; Sleight P; Young A; Collins R;
    Lancet; 2011 Jun; 377(9784):2181-92. PubMed ID: 21663949
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liraglutide: a review of the first once-daily GLP-1 receptor agonist.
    Bode B
    Am J Manag Care; 2011 Mar; 17(2 Suppl):S59-70. PubMed ID: 21517658
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.